Induction therapy in acute myeloid leukemia: Is it time to put aside standard 3 + 7?
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.2615
Abstract: For more than 30 years after its introduction, the combination of an anthracycline, usually daunorubicin, given for 3 days with continuous infusion of cytarabine for 7 days (3 + 7) has been the standard induction… read more here.
Keywords: induction therapy; myeloid leukemia; standard induction; acute myeloid ... See more keywords